UFC middleweight David Branch will have to sit out until 2021 after receiving a two-year suspension from USADA following a failed drug test.
The news of the suspension was announced by USADA (United States Anti-Doping Agency) on Wednesday as the administrators of the UFC’s anti-doping policy.
“Branch, 37, tested positive for ipamorelin as the result of a urine sample he provided out-of-competition on May 24, 2019. Ipamorelin is in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency Prohibited List,” USADA officials wrote in a statement.